Anuh Pharma Ltd.
BSE: 506260 | Sector: Health care |
NSE: N.A. | ISIN Code: INE489G01022 |
BSE 10:20 | 28 Jan | 125.50 |
-0.90 (-0.71%) |
OPEN
125.25 |
HIGH
126.90 |
LOW
124.30 |
NSE 05:30 | 01 Jan | Anuh Pharma Ltd |
OPEN | 125.25 |
PREVIOUS CLOSE | 126.40 |
VOLUME | 5203 |
52-Week high | 218.70 |
52-Week low | 48.70 |
P/E | 21.86 |
Mkt Cap.(Rs cr) | 629 |
Buy Price | 125.50 |
Buy Qty | 37.00 |
Sell Price | 125.55 |
Sell Qty | 225.00 |
Anuh Pharma Ltd. (ANUHPHARMA) - News Sector
-
Dr Reddy's Labs terminates Kuwait-based Covid-19 treatment study
5.58 pm | 27 Jan 2021 | Press Trust of India
Dr Reddy's Laboratories on Wednesday announced termination of Avigan trial study being conducted in Kuwait
-
Stock calls by Nilesh Jain of Anand Rathi: Buy Pidilite, Godrej Industries
8.45 am | 27 Jan 2021 | Business Standard
Pidilite's stock is in a secular uptrend and has formed a bullish Harami candlestick pattern on the daily chart
-
Pfizer wants India to order Covid-19 vaccine before pursuing nod
12.06 am | 26 Jan 2021 | Reuters
Pfizer says its application is supported by data from a global study that shows an overall efficacy rate of 95% with no vaccine-related, serious safet...
-
Dr Reddy's, Zuventus get nod to conduct Covid-19 trials on repurposed drugs
11.58 pm | 25 Jan 2021 | Business Standard
NeuroRx and Relief Therapeutics have partnered to develop a drug called RLF-100 that has anti-inflammatory and anti-cytokine activity properties.
-
Apollo Hospitals gains 4%, hits new high on successful fund raising via QIP
1.59 pm | 25 Jan 2021 | Business Standard
Apollo Hospitals said it will use the funds raised to acquire a 50 per cent stake in a joint venture, seek inorganic growth opportunities, as well as,...
-
Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs
10.46 am | 25 Jan 2021 | Business Standard
Aurobindo Pharma (through Lyfius Pharma) has received government approval for setting up plants for production of Penicillin-G and 7-ACA, under the PL...
-
Biocon stock slides on poor Q3 results, exit of biologics arm's MD
12.44 am | 23 Jan 2021 | Business Standard
From its previous close of Rs 441.95 apiece on Thursday, the stock closed 10.89 per cent or Rs 48.15 lower at Rs 393.80, on Friday
-
Market reacts negatively to Biocon's weaker results, exit of biologics' MD
1.15 pm | 22 Jan 2021 | Business Standard
Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher's exit due to "professional differences"
-
SBI, ITC, Titan: Over 50% of Sensex constituents look weak on charts
12.57 pm | 22 Jan 2021 | Business Standard
Technical indicators show that Bharti Airtel, Sun Pharmaceutical Industries, and ONGC are not showing an optimistic view from a short-term perspective
-
SBI, ITC, Titan: Over 50% of Sensex constituents look weak on charts
12.57 pm | 22 Jan 2021 | Business Standard
Technical indicators show that Bharti Airtel, Sun Pharmaceutical Industries, and ONGC are not showing an optimistic view from a short-term perspective
-
Biocon tanks 10% on lower-than-expected December quarter results
10.26 am | 22 Jan 2021 | Business Standard
Due to professional differences with the chairperson on strategic priorities and the vision for the company, Dr Christiane Hamacher has stepped down a...
-
Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
1.00 am | 22 Jan 2021 | Business Standard
Biocon's consolidated revenue for Q3 of FY21 increased by 7.20 per cent at Rs 1878.9 crore as against Rs 1752.6 crore for the said quarter last year
-
Alembic Pharma extends decline on mixed December quarter results
10.25 am | 20 Jan 2021 | Business Standard
Motilal Oswal Securities said Alembic Pharma missed Q3FY21 earnings estimate, weighed by lower-than-expected sales in the US
-
Apollo Hospitals hits record high on launch of Rs 1,000-crore QIP
3.14 pm | 19 Jan 2021 | Business Standard
The final issue price, including any discount to the floor price, will be determined in the fund-raising committee meeting on January 22, 2021
-
Piramal Enterprises: DHFL acquisition fast-forwards retail aspiration
11.36 pm | 18 Jan 2021 | Business Standard
Integration may take about six months, though execution may be a tightrope walk
-
New product launches to drive growth for Lupin, US business a key trigger
9.36 pm | 18 Jan 2021 | Business Standard
This should reverse the US underperformance in FY15-20 with margins too moving up sharply
-
Apollo Hospitals opens QIP with floor price of Rs 2,508.58 a share
8.11 pm | 18 Jan 2021 | Business Standard
Sources said that the hospital chain is targeting large Domestic Mutual Funds, Sovereign Funds
-
Metropolis Healthcare to acquire Chennai-based diagnostic lab for Rs 511 cr
9.31 am | 18 Jan 2021 | Business Standard
Metropolis will acquire 100 per cent equity of Dr Ganesan's Hitech Diagnostic Centre in a cash and stock deal
-
Stocks to watch: HDFC Bank, Metropolis Healthcare, Wipro, Airtel, DHFL
8.48 am | 18 Jan 2021 | Business Standard
Metropolis Healthcare said it will acquire Dr Ganesan's Hitech Diagnostic Centre
-
Here is a derivative strategy for Cadila Health by Vinay Rajani of HDFC Sec
7.22 am | 15 Jan 2021 | Business Standard
The stock price of Cadila Healthcare has broken out from the consolidation which held for last three weeks
Quick Links for Anuh Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices